V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004355 | 300003058 | 1.63 | 55 | Curative (C) | 2014-08-09 | 2014-09-11 | CISPLATIN + FLUOROURACIL + RT | N | Y | 300023314 | FLUOROURACIL + MITOMYCIN |
| 300004356 | 300003059 | 1.58 | 69 | Palliative (P) | 2016-12-08 | 2016-12-28 | Carboplatin + Cetux + FU (>Cycle 2) | 01 | null | 300023320 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004357 | 300003060 | 1.84 | 62.6 | Adjuvant (A) | 2018-01-15 | 2018-01-22 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 300023332 | CARBOPLATIN |
| 300004358 | 300003061 | 1.74 | 59.3 | Adjuvant (A) | 2013-10-18 | 2013-10-28 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 300023336 | DARS TRIAL |
| 300004359 | 300003062 | 1.66 | 91 | Palliative (P) | 2016-02-20 | 2016-02-22 | Carboplatin + Etoposide iv&po | 02 | N | 300023341 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004360 | 300003062 | 1.72 | 106 | Curative (C) | 2014-07-28 | 2014-08-20 | ESPAC-4 TRIAL | 02 | Y | 300023341 | CAPECITABINE + IRINOTECAN |
| 300004361 | 300003062 | 1.8 | 81 | Palliative (P) | 2018-01-15 | 2018-01-15 | Oxaliplatin + Modified de Gramont | 2 | N | 300023341 | CAPECITABINE + OXALIPLATIN |
| 300004362 | 300003062 | 1.75 | 85.35 | Curative (C) | 2014-02-03 | 2014-02-25 | CARBOPLATIN + RT | N | N | 300023341 | NIVOLUMAB |
| 300004363 | 300003063 | 1.69 | 76 | Adjuvant (A) | 2014-11-30 | 2014-12-02 | CARBOPLATIN + RT | 02 | null | 300023390 | DE-ESCALATE TRIAL |
| 300004364 | 300003064 | null | 55.6 | Palliative (P) | 2013-08-15 | 2013-08-22 | Rituximab (Maintenance) | N | N | 300023394 | ESPAC TRIAL |
| 300004365 | 300003064 | 1.69 | 71 | Palliative (P) | 2013-08-08 | 2013-08-09 | Carboplatin + Etoposide IV 3 day | 02 | N | 300023394 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004366 | 300003064 | 1.67 | 72.9 | Adjuvant (A) | 2017-11-24 | 2017-11-24 | Carboplatin AUC 6 - 10 | Y | N | 300023394 | CARBO + FLUOROURACIL |
| 300004367 | 300003064 | 1.74 | 87.5 | Adjuvant (A) | 2014-08-18 | 2014-08-26 | FLUOROURACIL | N | N | 300023394 | CARBOPLATIN + RT |
| 300004368 | 300003064 | 1.6 | 63 | Adjuvant (A) | 2016-05-06 | 2016-05-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 300023394 | FEC + DOCETAXEL |
| 300004369 | 300003065 | 1.53 | 47.2 | Adjuvant (A) | 2016-05-08 | 2016-05-08 | Bevacizumab 7.5mg/kg | 2 | N | 300023425 | CAPECITABINE + OXALIPLATIN |
| 300004370 | 300003065 | 1.67 | 77 | Palliative (P) | 2016-12-29 | 2017-01-05 | ESPAC-4 TRIAL | 02 | N | 300023425 | CARBOPLATIN + RT |
| 300004371 | 300003066 | 1.88 | null | null | 2013-12-21 | 2013-12-25 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | null | 300023433 | GEMCARBO |
| 300004372 | 300003067 | 1.6 | 52 | Adjuvant (A) | 2014-01-01 | 2014-01-16 | ESPAC-4 TRIAL | 01 | N | 300023441 | FLUOROURACIL + MITOMYCIN |
| 300004373 | 300003068 | 1.77 | 71.5 | Curative (C) | 2014-05-22 | 2014-06-06 | ESPAC-4 TRIAL | N | N | 300023445 | ESPAC TRIAL |
| 300004374 | 300003069 | 1.59 | 84 | Palliative (P) | null | 2015-03-24 | Carbo F | N | N | 300023449 | CISPLATIN + FLUOROURACIL + RT |
| 300004375 | 300003070 | 1.66 | 88.2 | Curative (C) | 2014-08-05 | 2014-08-12 | PEMBROLIZUMAB | 2 | N | 300023463 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004376 | 300003070 | 1.77 | 64.6 | Curative (C) | 2016-04-13 | 2016-04-13 | NIVOLUMAB | N | N | 300023463 | CARBOPLATIN + RT |
| 300004377 | 300003070 | 1.52 | 57 | Adjuvant (A) | null | 2017-12-05 | FEC + DOCETAXEL | N | N | 300023463 | CAPECITABINE + CARBOPLATIN |
| 300004378 | 300003071 | 1.8 | 137 | Palliative (P) | 2013-06-23 | 2013-06-25 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | null | 300023471 | ECARBOX |
| 300004381 | 300003073 | 1.61 | 57.2 | Adjuvant (A) | 2014-06-12 | 2014-06-12 | Folfirinox | 2 | N | 300023480 | DE-ESCALATE TRIAL |
| 300004382 | 300003074 | 1.65 | null | Adjuvant (A) | 2017-06-28 | 2017-07-05 | FEC + DOCETAXEL | N | N | 300023483 | CARBOPLATIN + RT |
| 300004386 | 300003076 | 1.64 | 54 | Palliative (P) | 2012-05-17 | 2012-06-06 | ESPAC-4 TRIAL | Y | N | 300023503 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004387 | 300003076 | 1.7 | 92.2 | Curative (C) | 2016-01-26 | 2016-01-27 | Gemcitabine + Capecitabine | 02 | N | 300023503 | CAPECITABINE + GEMCITABINE |
| 300004388 | 300003077 | 1.75 | 94 | null | 2014-08-01 | 2014-08-08 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 300023509 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004389 | 300003077 | 1.65 | 81.9 | Palliative (P) | null | 2014-09-17 | PEMBROLIZUMAB | null | null | 300023509 | PACLITAXEL |
| 300004390 | 300003078 | 1.66 | null | null | 2014-02-24 | 2014-03-23 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 300023518 | ENZALUTAMIDE |
| 300004391 | 300003079 | 1.65 | 71 | Adjuvant (A) | 2013-09-10 | 2013-10-01 | ESPAC-4 TRIAL | N | N | 300023526 | CAPECITABINE + GEMCITABINE |
| 300004392 | 300003079 | 1.83 | 72 | null | 2014-10-28 | 2014-11-09 | Carboplatin AUC 2 - 5 | N | N | 300023526 | CARBO + FLUOROURACIL |
| 300004393 | 300003079 | 1.56 | 57 | Palliative (P) | 2018-01-15 | 2018-01-15 | CARBOPLATIN + GEMCITABINE | 02 | null | 300023526 | CISPLATIN + FLUOROURACIL + RT |
| 300004394 | 300003080 | 1.7 | 49.5 | Adjuvant (A) | 2013-08-11 | 2013-08-24 | Gemcitabine + Capecitabine | 2 | N | 300023549 | TCF |
| 300004395 | 300003080 | 1.59 | null | Palliative (P) | 2017-03-05 | 2017-03-06 | ESPAC-4 TRIAL | Y | N | 300023549 | CISPLATIN + VINORELBINE |
| 300004396 | 300003080 | 1.8 | 92.5 | null | 2017-10-25 | 2017-11-16 | Gemcitabine + Capecitabine | N | N | 300023549 | DE-ESCALATE TRIAL |
| 300004397 | 300003081 | 1.53 | 68.4 | Curative (C) | 2018-01-11 | 2018-01-20 | EC | 02 | null | 300023557 | ESPAC TRIAL |
| 300004398 | 300003082 | 1.82 | 72 | Palliative (P) | 2014-10-20 | 2015-01-14 | ESPAC-4 TRIAL | N | N | 300023558 | VINBLASTINE |
| 300004399 | 300003083 | null | 63.5 | Palliative (P) | 2014-02-28 | 2014-03-01 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 300023568 | FEC + DOCETAXEL |
| 300004400 | 300003084 | null | 89 | Adjuvant (A) | 2016-07-03 | 2016-07-10 | ESPAC-4 TRIAL | 99 | Y | 300023575 | CARBOPLATIN |
| 300004401 | 300003085 | null | 42.5 | Curative (C) | 2015-04-03 | 2015-04-03 | Carboplatin AUC 2 - 5 | 02 | N | 300023583 | PEMBROLIZUMAB |
| 300004402 | 300003086 | 1.69 | 75.3 | Palliative (P) | 2017-09-15 | 2017-10-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 300023584 | BCG |
| 300004403 | 300003086 | null | 76 | Palliative (P) | 2013-06-26 | 2013-07-17 | FEC 60 or 75 | N | N | 300023584 | FLUOROURACIL + MITOMYCIN |
| 300004404 | 300003086 | 1.48 | null | Palliative (P) | 2014-08-03 | 2014-08-07 | MAESTRO TRIAL | N | N | 300023584 | GEMCARBO |
| 300004406 | 300003088 | 1.66 | 44.6 | Adjuvant (A) | 2016-03-13 | 2016-04-04 | RUXOLITINIB | 02 | null | 300023608 | PEMBROLIZUMAB |
| 300004408 | 300003090 | 1.66 | 88 | Disease modification (D) | 2013-10-25 | 2013-11-15 | Capecitabine + Mitomycin | 02 | N | 300023613 | ESPAC TRIAL |
| 300004409 | 300003091 | 1.82 | 85.45 | Curative (C) | 2015-10-31 | 2015-12-03 | GemCarbo Days 1+8 | N | Y | 300023614 | CARBOPLATIN |
| 300004410 | 300006117 | 1.58 | 62.2 | Curative (C) | 2016-10-26 | 2016-11-18 | FLUOROURACIL + MITOMYCIN | N | Y | 300023615 | ESPAC TRIAL |
| 300004411 | 300003092 | null | null | Palliative (P) | 2015-02-20 | 2015-03-05 | Ipilimumab | null | N | 300023622 | CARBOPLATIN |